Ishares Medical Devices Etf Performance

IHI Etf  USD 60.46  0.85  1.43%   
The etf retains a Market Volatility (i.e., Beta) of 0.031, which attests to not very significant fluctuations relative to the market. As returns on the market increase, IShares Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding IShares Medical is expected to be smaller as well.

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in iShares Medical Devices are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong technical indicators, IShares Medical is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
In Threey Sharp Ratio0.02
  

IShares Medical Relative Risk vs. Return Landscape

If you would invest  5,949  in iShares Medical Devices on December 25, 2024 and sell it today you would earn a total of  97.00  from holding iShares Medical Devices or generate 1.63% return on investment over 90 days. iShares Medical Devices is generating 0.0322% of daily returns assuming volatility of 0.9849% on return distribution over 90 days investment horizon. In other words, 8% of etfs are less volatile than IShares, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon IShares Medical is expected to generate 1.14 times more return on investment than the market. However, the company is 1.14 times more volatile than its market benchmark. It trades about 0.03 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.03 per unit of risk.

IShares Medical Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for IShares Medical's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as iShares Medical Devices, and traders can use it to determine the average amount a IShares Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0327

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsIHI

Estimated Market Risk

 0.98
  actual daily
8
92% of assets are more volatile

Expected Return

 0.03
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.03
  actual daily
2
98% of assets perform better
Based on monthly moving average IShares Medical is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IShares Medical by adding it to a well-diversified portfolio.

IShares Medical Fundamentals Growth

IShares Etf prices reflect investors' perceptions of the future prospects and financial health of IShares Medical, and IShares Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IShares Etf performance.

About IShares Medical Performance

By evaluating IShares Medical's fundamental ratios, stakeholders can gain valuable insights into IShares Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if IShares Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if IShares Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
The fund will invest at least 80 percent of its assets in the component securities of the index and in investments that are substantially identical to the component securities of the index and may invest up to 20 percent of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the index, but which BFA believes will help the fund track the index. US Medical is traded on NYSEARCA Exchange in the United States.
The fund retains 99.78% of its assets under management (AUM) in equities
When determining whether iShares Medical Devices offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IShares Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ishares Medical Devices Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ishares Medical Devices Etf:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Medical Devices. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
The market value of iShares Medical Devices is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Medical's value that differs from its market value or its book value, called intrinsic value, which is IShares Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Medical's market value can be influenced by many factors that don't directly affect IShares Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.